Decision-making places in Alzheimer’s dementia – Study part 1: Supporting health-related advance care planning

Decision-making places in Alzheimer’s dementia – Study part 1: Supporting health-related advance care planning - DECIDE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00026691

Enrollment

250

Registered

2021-10-15

Start date

2021-11-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00 F02 F03 F06.7 F01

Interventions

Group 1: Intervention phase (25 weeks

after the paseline phase (see below)): Memory clinic patients are offered the opportunity to take part in an Advance Care Planning Process. If accepting, the are offered additional appointments by the

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: new Memory Clinic patient with suspected dementia. The inclusion process will rely on the decision tree for the incusion into medical research of persons inable to consent by Scholten et al. (in preparation) in order to include, where possible, individuals for whom capacity to consent is no longer certain

Exclusion criteria

Exclusion criteria: severe dementia, delirium, intellectual disability, severe psychiatric illness, insufficient ability to consent to medical research with concurrent inability for supported decisicion making by a relative or other proxy, uncompensated sensoric deficits, insufficient command of the German language preventing the understanding of the study documents or the interview

Design outcomes

Primary

Measure	Time frame
proportion of valid advance directives as assessed by a studyspecific questionnaire. We assess a.) the existence of an advance directive, as well as b.) its validity. Validity is assessed by the following cirteria: adequate information (Has counceling by a physician taken place? Has counceling by a notary taken place?), ability to consent (Has your ability to consent been documented by the physiscian or notary at the time when the advance directive was issued?), voluntariness (Have you made the advance directive voluntarily?). The answers to these questions are assessed at both assessments, T1 and T2 (see above).	—

Measure

Time frame

proportion of valid advance directives as assessed by a studyspecific questionnaire. We assess a.) the existence of an advance directive, as well as b.) its validity. Validity is assessed by the following cirteria: adequate information (Has counceling by a physician taken place? Has counceling by a notary taken place?), ability to consent (Has your ability to consent been documented by the physiscian or notary at the time when the advance directive was issued?), voluntariness (Have you made the advance directive voluntarily?). The answers to these questions are assessed at both assessments, T1 and T2 (see above).

—

Secondary

Measure	Time frame
patients' satisfaction with advance directive is assessed as single items for reasons of parsimony: "How much to you agree to the following statement: 'I am satisfied with my advance directive.' ", which is assessed on a five-point Likert scale. It is assessed at both assessments T1 and T2.	—

Countries

Germany

Contacts

Public ContactDaniel Garmann

Universität Siegen, Fakultät 5, Abteilung Psychologische Alternsforschung

daniel.garmann@uni-siegen.de02717405008

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026